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Poster Session II S369greatly impacts their quality of life. Bedside nurses accompany these
patients and families on this journey and while educating and provid-
ing comfort along the way, these nurses advocate for assistance with
the larger multidisciplinary team to address the patient and family’s
concerns of comfort, quality of life, and possible outcomes.
The PBMTU Quality of Life Project (QoL) was created to em-
power the nurse to better identify, communicate, and assist the fam-
ily’s daily quality of life needs. The goal of the QoL Project is to
improve communication between patients, families, and the multi-
disciplinary medical care team, ensuring that conversations regard-
ing quality of life occur, are conveyed and understood by the entire
team, and a plan is developed which is tailored to that specific patient
and family’s desires. This ensures the path the patient follows is one
that has been fully understood and agreed upon by them and their
family, taking all factors into consideration. In turn, having the entire
medical team updated on the patient’s and families QoL choices
gives the nursing staff relief knowing that these issues have been ad-
dressed and the knowledge to continue caring for the patients effec-
tively and with regard to their specific desires.
TheQoL Project was submitted to the PBMTProgram’s Medical
Director in July 2009. After approval an assessment survey was com-
pleted with the nursing staff in August 2009. The results of the sur-
vey were presented to the entire PBMT Program which generated
many ideas and increased awareness for areas of improvements. After
six months of QoL interventions, in March 2010 the survey was re-
peated. A comparison of the two surveys, review of the interventions
and goals for the future were presented to the medical team in May
2010. The QoL Project was so successful that it has continued to
grow and is having a positive impact on the unit.
The oral presentation will begin with a slide show describing the
history, comparisons the two surveys, interventions, and suggestions
for the future, after which a discussion will take place.608
MANAGEMENT OF NAUSEA AND VOMITING IN THE PEDIATRIC BLOOD
AND MARROW TRANSPLANT SETTING – ARE WE COVERING ALL OF
OUR BASES? A NURSING PERSPECTIVE
Rowland, P. Children’s Healthcare System, Birmingham, AL
The challenge of managing nausea and vomiting (N/V) in the pe-
diatric blood and marrow transplant (BMT) setting is compounded
by multiday chemotherapy/radiation regimens and concomitant
treatments unique to the BMT process. Younger age has been iden-
tified as a particular risk for chemotherapy induced N/V thus in-
creasing the challenge further. An understanding of emetic
pathways affected by these treatments and medications recommen-
ded for each is essential to manage N/V effectively. Several organi-
zations have developed guidelines for antiemetic treatment. Many
recommendations are based on identification and blockage of emetic
pathways. While some organizations briefly address antiemetic rec-
ommendation for the pediatric population, none provide guidelines
for pediatric antiemetic recommendations in the BMT setting.
An evidence based practice group consisting of 13 pediatric BMT
nurses, one data manager, one supportive assistant and one pediatric
BMT nurse practitioner conducted a single institutional chart re-
view. Available medical charts of pediatric patients transplanted at
Alabama’s Childrens Healthcare System between Jan 2008 and April
2010 were reviewed to assess efficacy of N/V management. A com-
parison of treatments to present adult guidelines was completed.
Emetogenic potential for each preparative regimen was graded using
Hesketh’s algorithm for defining emetogenicity of combination reg-
imens. The Common Terminology Criteria for Adverse Events v3.0
(CTCAE) was utilized as a guideline to evaluate severity of daily
N/V.
Results of the chart review prompted a search of literature that
may provide information for treatment of N/V specific to the pedi-
atric population in the BMT setting. There were few articles ad-
dressing concerns of N/V in the pediatric population. It is the
recommendation of the EBP group that focus on research specific
to management of N/V in the pediatric BMT population become
a priority facilitating development of Antiemetic Guidelines specific
to the BMT pediatric population.609
THE POWER OF PROCESS IMPROVEMENT METHODOLOGY ON A HIGHLY
COMPLEX PEDIATRIC BONE MARROW TRANSPLANT UNIT’S CATHETER
ASSOCIATED BLOOD STREAM INFECTION RATES
Flesch, L.1, Demmel, K.M.1, Davies, S.M.1, Nagarajan, R.1,
Hawkins, D.1, Hutchinson, N.2, Bierman, L.1, Fellers, E.1, Hodapp, S.1,
O’Hara, E.1, Shelton, C.1, Curry, C.2, Giesken, R.2, Spear, S.3,
Wheeler, D.2, Giaccone, M.2 1Cincinnati Children’s Hospital Medical
Center, Cincinnati, OH; 2Cincinnati Children’s Hospital Medical Center,
Cincinnati, OH; 3Cincinnati Children’s Hospital Medical Center, Cincin-
nati, OH
Cincinnati Children’sHospitalMedical Center (CCHMC) has in-
stituted a major safety initiative to reduce central venous catheter
(CVC) blood stream infections (BSI). A multidisciplinary approach
utilizing quality improvement methodology was implemented ini-
tially in the PICU, leading to the development of a CVC mainte-
nance bundle.
With the bundle’s success, it was spread to CCHMC’s BMT pro-
gram that had the highest CVC BSI rates. The program, a highly
complex intensive care environment, completed 108 transplants in
2009 with approximately 70% unrelated, 10% matched sibling and
20% autologous. Until this point, line infections were viewed as a di-
rect treatment result leading to mucositis and increased vulnerability
to infection.
Initial support of this initiative was met with much resistance. On-
going communication regarding bundle progress and staff involve-
ment in the initiative through a unit based task force and
a national collaborative resulted in an augmented bundle. A signifi-
cant culture change with acceptance occurred as well. Staff has em-
braced responsibility for overall line infection rates and proactively
identifies infection prevention opportunities.
Ongoing tests of change created an enhanced bundle addressing
the unique challenges of a highly immune compromised population.
The bundle has evolved and includes line entry minimization, daily
line assessment, hand hygiene and site, line, and cap care practices.
The tests included evidence based product changes and review of
catheter and line practices. Specifically, weekly dressing changes,
the use of a biopatch, an occlusive transparent dressing, gloving
with all line care, a 30 second chlorhexidine scrub with every line en-
try, use of a positive pressure cap and masking of all parties during
sterile procedures were additional bundle elements.
CVC BSI rates have changed significantly. In 2006, the rate
reached 6.35 infections per 1000 catheter days. As of June 2010,
the rate was reduced to 1.68 infections per 1000 catheter days result-
ing in a 74% rate reduction.
Table 1. Cincinnati Children’s Hospital Medical Center Bone
Marrow Transplant Unit CVC BSI Rates
CVC BSI Per






INCREASED MOBILITY AND COMMITMENT TO EXERCISE DURING
HOSPITALIZATION HAS A POSITIVE EFFECT ON OUTCOMES FOR BONE
MARROW TRANSPLANT PATIENTS AT UNIVERSITY OF ALABAMA
HOSPITAL
Howard, R., McCay, W., Dockery, J., Madden, W. UAB, Birmingham,
AL
The Bone Marrow Transplant program staff at the University of
Alabama Hospital used a collaborative partnership approach with
their patients to increase and record physical activity in order to im-
prove clinical outcomes. Participants were encouraged to walk laps
around the unit and record their progress. Exercising in the hallways
S370 Poster Session IIof the unit enabled them to increase their physical activity while stay-
ing in an area of modified protective isolation to protect their immu-
nity. The nursing staff of the BMT unit took a physical fitness
instructor approach to selected patients beginning with their admis-
sion. A formal contract was signed by the patients with an agreement
to participate in the project. Physical activity goals were set with the
BMT patients on admission and were then measured daily. The unit
was marked off with indicators for measuring distance for those who
chose to walk the hallways to increase their physical activity. Exercise
bicycles were also available for use and time used was measured.
Achieved goals were celebrated by the unit and prizes were given
for overall patients who met their goals. Outcomes were measured
against previous quarter Bone Marrow Transplant program data in
which physical activity was suggested but without the special atten-
tion and extra encouragement that was given during the project. Pos-
tive correlations were measured between the increased physical
activity and length of stay, deep vein thrombosis incidence, engraft-
ment date, pneumonia incidence, bacteremia, fever, and complaints
of insomnia. The results revealed a decrease in complaints of insom-
nia due to increased activity during the day andmore sleep during the
night. There was no incidence of pneumonia in these selected
patients. More research is needed to validate findings and project
is currently ongoing.611
MAKING A DIFFERENCE: DEVELOPMENT AND IMPLEMENTATION OF A
POST-INSERTION CENTRAL LINE CARE BUNDLE IN HSCT PATIENTS
Mary-Gonzales, K.K., Sowell, H.V., Caga, U., Dean, D.D.,
MacPherson, J., Elledge, C. Methodist Health Care System, San Antonio,
TX
Patients undergoing hematopoietic stem cell transplantation
(HSCT) are at risk for multiple life-threatening complications dur-
ing and following treatment, including catheter related bloodstream
infections (CRBSIs). In 2009, we noted a hospital wide increase in
CRBSIs. To address this concerning trend, our HSCT unit initiated
a program to minimize this impact for our patients. We conducted
an initial literature review that included gathering data from other
similar care units. We developed and piloted two tracking tools to
monitor compliance with the current dressing change, cap change,
and implanted port needle change policies. After implementation,
we selected the more useful of the two tools to move forward. Fol-
lowing our initial data collection, we initiated a new standard of
care for HSCT patients on our unit and monitored compliance
and CRBSIs for a proposed period of 12 months. To date (Janu-
ary-September 2010), we have had 2 documented CRBSIs in our in-
patient population,that is far below the national average. This poster
presentation will highlight the process we undertook to impact
CRBSIs in our HSCT population, including tool development,
our evidence-based dressing change procedure, and finally, nursing
and patient education.612
EDUCATING PEDIATRIC OUTPATIENT NURSES TO THE UNIQUE
CHALLENGES OF REDUCED INTENSITY TRANSPLANT CONDITIONING
(RIC) REGIMEN IN CHILDREN WITH NON-MALIGNANT DISORDERS
Hollowell, R.M.1, Cash, J.V.2, Stokhuyzen, A.R.2, Szabolcs, P.2,
Kurtzberg, J.2, Parikh, S.H.2 1Duke University Hospital, Durham,
NC; 2Duke University Hospital, Durham, NC
In recent years, many advances have been made in the field of he-
matopoietic stem cell transplantation, an important treatment op-
tion for children with certain malignant and non-malignant
diseases. Unrelated umbilical cord blood (UCB) is a viable donor
source for hematopoietic reconstitution for these patients due to
its rich numbers of stem and progenitor cells, and its tolerance to
HLA mismatches. Traditionally, the pediatric conditioning regi-
mens have been myeloablative, which are associated with significant
acute and long-term toxicities. Recently, RIC regimens have proven
to provide sufficient immunosuppression to attain acceptable rates ofdonor cell engraftment in patients with certain diseases. However,
use of these regimens using cord blood donors has been challenging
because of higher rates of graft failure. The PBMT program at Duke
is testing a new transplant protocol for children with non-malignant
diseases using UCB donors and slightly lower intensity chemother-
apy that is more immunosuppressive.
The Duke RIC consists of alemtuzumab, hydroxyurea (HU), flu-
darabine (FLU), melphalan, and thiotepa. A portion of the condi-
tioning therapy (alemtuzmab, HU and FLU) is completed in our
outpatient day hospital. Clinic nurses are responsible for coordinat-
ing adequate staffing, educating patients and families, and adminis-
tering alemtuzumab and FLU. Oral HU involves collaborating
with mid-level providers for monitoring patient’s blood counts and
educating families if dose adjustments are needed. Although clinic
nurses will have general knowledge of immunosuppression and
potentially reactive medications, there are some unique challenges
pertaining to reduced intensity transplant that require specific
education.
We will highlight the key points related to outpatient nursing care
of pediatric patients undergoing reduced intensity transplants at
Duke University Hospital. This will include comprehensive educa-
tion on medication administration and practice standards with a spe-
cial focus on alemtuzumab safety as it applies to the pediatric patient
in the clinic setting. Additionally we will review precautions for neu-
tropenic and immunodeficient patients. Patient education will be de-
signed to minimize potential side effects and to ensure patient safety.
Following our presentation, nurses are expected to have a broader
understanding of reduced intensity transplant, specific patient care
needs, and family education pertinent to our reduced intensity
protocol.613
IMPLEMENTING A BONE MARROW BIOPSY PERFORMANCE IMPROVE-
MENT PLAN: FOCUS ON EXCELLENCE
Rimkus, C., Ward, V., Press, B., Cliver, P., Garavaglia, K.,
Wischmeier, J., Wilson, C., Divanbeigi, J. Washington University, St.
Louis, MO
Bone marrow biopsies and aspirates (BMBA) have traditionally
been performed by Licensed Independent Practitioners. In 1994,
two large academic centers in a Midwestern metropolitan city iden-
tified the need for registered nurses (RN) to help with BMBA. These
academic centers cooperated and submitted the paperwork to the
State Board of Nursing requesting the expansion of scope to allow
specially trained RN’s to perform BMBA. After the State Board ap-
proved this request, one of the academic centers implemented an RN
run outpatient BMBA program. The program started with one RN
and has expanded to six RN’s who rotate through the biopsy center
as well as administer chemotherapy. These RN’s perform over 1500
BMBA annually. Over the past few years, the program has rapidly ex-
panded leading to challenges offering opportunities for improve-
ment. The Advanced Practice Nurse (APN) worked with the
BMBA nursing team to embark on a project to evaluate BMBA
and initiate process improvement (PI) as indicated. The APN pre-
sented a proposal to the physician team and the stem cell transplant
QI committee. The proposal was accepted and welcomed by all. The
PI group reviewed every aspect of BMBA and identified opportuni-
ties for improvement including; need for formal ongoing training re-
garding new testing and discussion sessions with pathology, flow and
cytogenetic laboratories; improving the accuracy of orders for special
testing written by the physician teams; identifying patient scheduling
and coordination errors; and lack of standardized nursing pre proce-
dure assessment. These challenges became more pronounced when
training new staff to do BMBA. The second step has been to imple-
ment processes based on the opportunities including; the develop-
ment of a pre procedure assessment consistent with national
standards; a specific BMBA consent form; a patient survey to deter-
mine patient satisfaction with RNBMBA, an agreed upon revised or-
der set that doubles as the lab requisition; an inservice for the RN’s
with the pathology department and scheduled rotations through the
different labs as well as the implementation of an error reporting
system. Outcomes thus far include; a decrease in the number of
